Lifespan Vision Ventures announced that it has closed its seventh investment. This marks another important step towards its mission of extending life expectancy. The venture capital firm dedicated to advancing the field of longevity biotechnology always remains unwavering

LifeSpan Vision Ventures' recent investment in Rejuvenation Technologies is the latest in a series of strategic investments, closely following the funding rounds of pioneering companies such as LIft Biosciences, Deciduous Therapeutics, and Fauna Bio, with other investments to be announced in the coming weeks. Harry Robb, an analyst at LifeSpan Vision Ventures, said he was delighted to unveil the seventh investment. “We are thrilled to unveil our seventh investment as we continue to move forward in the area of longevity.”

According to the latter, the company's commitment to extending lifespan and enabling longer, healthier, and more satisfying lives for all, remains at the heart of the mission.